HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Ronald N Jones Selected Research

gatifloxacin (Zymar)

2/2012Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.
6/2006Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003).
6/2004Use of pharmacodynamic end points in the evaluation of gatifloxacin for the treatment of acute maxillary sinusitis.
1/2003Worldwide antimicrobial susceptibility patterns and pharmacodynamic comparisons of gatifloxacin and levofloxacin against Streptococcus pneumoniae: report from the Antimicrobial Resistance Rate Epidemiology Study Team.
9/2002Gatifloxacin phase IV surveillance trial (TeqCES study) utilizing 5000 primary care physician practices: report of pathogens isolated and susceptibility patterns in community-acquired respiratory tract infections.
9/2002Implications of TeqCES: efficacy and safety of gatifloxacin in community-acquired pneumonia.
9/2002Haemophilus influenzae in respiratory tract infections in community-based clinical practice: therapy with gatifloxacin.
9/2002Gatifloxacin used for therapy of outpatient community-acquired pneumonia caused by Streptococcus pneumoniae.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Ronald N Jones Research Topics

Disease

138Infection
01/2016 - 02/2002
31Respiratory Tract Infections (Respiratory Tract Infection)
04/2014 - 05/2002
27Pneumonia (Pneumonitis)
01/2015 - 03/2002
15Soft Tissue Infections
02/2015 - 08/2002
10Bacterial Pneumonia
03/2015 - 06/2010
7Urinary Tract Infections (Urinary Tract Infection)
11/2014 - 07/2002
5Neoplasms (Cancer)
07/2010 - 01/2003
4Ventilator-Associated Pneumonia (Pneumonia, Ventilator Associated)
07/2015 - 07/2014
4Bacterial Infections (Bacterial Infection)
09/2013 - 03/2002
4Endocarditis
08/2013 - 04/2005
4Pneumococcal Infections
06/2010 - 11/2002
4Maxillary Sinusitis
05/2008 - 11/2003
4Chronic Bronchitis
02/2007 - 09/2002
4Community-Acquired Infections
07/2005 - 05/2003
3Meningitis
03/2014 - 01/2003
3Sinusitis
05/2007 - 09/2002
3Otitis Media
02/2007 - 11/2003
3Cross Infection (Nosocomial Infection)
09/2003 - 02/2003
2Diarrhea
03/2011 - 03/2009
2Pharyngitis (Sore Throat)
02/2007 - 11/2003
2Bacteremia
01/2007 - 11/2002
2Wound Infection (Wound Infections)
01/2006 - 04/2005
2Respiratory Tract Diseases (Respiratory Tract Disease)
04/2005 - 07/2004
2Sepsis (Septicemia)
04/2005 - 03/2002
1Ulcer
03/2015
1Diabetic Foot
03/2015
1Chronic Kidney Failure (Chronic Renal Failure)
12/2014
1Cardiomyopathies (Cardiomyopathy)
08/2013
1Gram-Negative Bacterial Infections
04/2013
1Critical Illness (Critically Ill)
04/2012

Drug/Important Bio-Agent (IBA)

22T 91825IBA
07/2015 - 06/2010
16FluoroquinolonesIBA
02/2012 - 02/2002
15linezolid (Zyvox)FDA Link
04/2014 - 07/2005
15VancomycinFDA LinkGeneric
07/2013 - 07/2002
13Anti-Infective Agents (Microbicides)IBA
12/2014 - 09/2002
13beta-Lactamases (beta-Lactamase)IBA
04/2014 - 05/2002
13tigecycline (Tygacil)FDA Link
06/2013 - 07/2004
11Penicillins (Penicillin)FDA Link
03/2014 - 07/2003
9DaptomycinFDA Link
07/2013 - 04/2004
8tazobactamFDA LinkGeneric
10/2014 - 05/2002
8gatifloxacin (Zymar)FDA Link
02/2012 - 09/2002
6Oxacillin (Prostaphlin)FDA LinkGeneric
07/2013 - 12/2004
6garenoxacinIBA
05/2007 - 05/2002
6Trimethoprim-Sulfamethoxazole Combination (Co-Trimoxazole)FDA LinkGeneric
04/2007 - 08/2003
5dalbavancinIBA
01/2016 - 02/2006
5Ceftazidime (Fortum)FDA LinkGeneric
08/2015 - 06/2014
5oritavancinIBA
02/2015 - 04/2012
5Cephalosporins (Cephalosporin Antibiotics)IBA
12/2013 - 11/2002
57- (3- (2- amino- 1- fluoroethylidene)- 1- piperidinyl)- 1- cyclopropyl- 6- fluoro- 1,4- dihydro- 8- methoxy- 4- oxo- 3- quinolinecarboxylic acidIBA
09/2012 - 07/2011
5peptide deformylaseIBA
11/2011 - 01/2004
5Carbon MonoxideIBA
02/2011 - 03/2002
5Carbapenems (Carbapenem Antibiotics)IBA
02/2010 - 11/2002
5cefepime (Maxipime)FDA LinkGeneric
04/2009 - 03/2002
5cefdinir (CFDN)FDA LinkGeneric
02/2007 - 11/2003
4CoagulaseIBA
05/2015 - 06/2006
4PPI-0903FDA Link
04/2015 - 09/2013
4telavancinIBA
01/2015 - 08/2010
4Ceftriaxone (Ceftriaxon)FDA LinkGeneric
03/2014 - 02/2005
4beta-LactamsIBA
12/2009 - 06/2005
4Ofloxacin (Levofloxacin)FDA LinkGeneric
05/2008 - 01/2003
4Erythromycin (Erycette)FDA LinkGeneric
03/2007 - 07/2003
4CL 331002 (glycylcycline)IBA
03/2007 - 07/2005
4TetracyclinesIBA
02/2007 - 07/2005
4NVP PDF 713IBA
05/2006 - 01/2004
3Antifungal AgentsIBA
10/2014 - 01/2003
3ceftobiproleIBA
04/2014 - 05/2008
3Polymyxins (Polymyxin)IBA
09/2013 - 02/2008
3Methicillin (Metin)FDA Link
07/2013 - 12/2009
3pleuromutilinIBA
05/2012 - 02/2002
3AminoglycosidesIBA
04/2012 - 03/2002
3meropenem (Merrem)FDA LinkGeneric
12/2009 - 08/2004
3Doxycycline (Vibramycin)FDA LinkGeneric
12/2004 - 02/2002
2EnzymesIBA
01/2015 - 09/2012
2EchinocandinsIBA
10/2014 - 03/2008
2TeicoplaninIBA
06/2012 - 09/2011
2Fusidic Acid (Fucithalmic)IBA
06/2011 - 03/2010
2CEM 101IBA
06/2010 - 04/2010
2cefditorenIBA
06/2009 - 06/2008
2doripenemFDA Link
04/2009 - 07/2006
2Serine (L-Serine)FDA Link
09/2008 - 02/2007
2omiganan pentahydrochlorideIBA
05/2008 - 03/2008
2PiperacillinFDA LinkGeneric
05/2008 - 05/2002
2Clindamycin (Cleocin)FDA LinkGeneric
03/2007 - 09/2006
2Ciprofloxacin (Cipro)FDA LinkGeneric
06/2006 - 03/2002
2Tetracycline (Achromycin)FDA LinkGeneric
02/2006 - 02/2002
2Polymyxin B (Aerosporin)FDA LinkGeneric
01/2006 - 09/2003
2Oxazolidinones (2 Oxazolidone)IBA
05/2005 - 05/2004
1pexigananIBA
03/2015
1Anti-Bacterial Agents (Antibiotics)IBA
03/2015
1habekacin (arbekacin)IBA
01/2015
1TriazolesIBA
10/2014
1ceftobiprole medocarilIBA
07/2014
1Cefazolin (Ancef)FDA LinkGeneric
12/2013
1BoronIBA
04/2013
1quinupristin-dalfopristin (Synercid)FDA Link
04/2012
1moxifloxacin (Avelox)FDA Link
02/2012
17- ((3R)- aminohexahydro- 1H- azepin- 1- yl)- 8- chloro- 1- cyclopropyl- 6- fluoro- 1,4- dihydro- 4- oxo- 3- quinolinecarboxylic acidIBA
02/2012

Therapy/Procedure

8Catheters
06/2012 - 02/2006
3Drug Therapy (Chemotherapy)
04/2014 - 01/2003
2Mechanical Ventilators (Ventilator)
11/2010 - 08/2010